Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy

被引:110
作者
Erdmann, J
Raible, J
Maki-Abadi, J
Hummel, M
Hammann, J
Wollnik, B
Frantz, E
Fleck, E
Hetzer, R
Regitz-Zagrosek, V
机构
[1] Humboldt Univ, Campus Virchow Klinikum, Charite, Dept Internal Med, D-13353 Berlin, Germany
[2] Humboldt Univ, Campus Virchow Klinikum, Charite, Dept Cardiol, D-13353 Berlin, Germany
[3] Deutesch Herzzentrum, Berlin, Germany
[4] Univ Istanbul, Inst Child Hlth, Dept Med Genet, Istanbul, Turkey
关键词
D O I
10.1016/S0735-1097(01)01387-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We studied the clinical and genetic features of hypertrophic cardiomyopathy (HCM) caused by mutations in the myosin-binding protein C gene (MYBPC3) in 110 consecutive, unrelated patients and family members of European descent. Background Mutations in the MYBPC3 gene represent the cause of HCM in similar to 15% of familial cases. MYBPC3 mutations were reported to include mainly nonsense versus missense mutations and to be characterized by a delayed onset and benign clinical course of the disease in Japanese and French families. We investigated the features that characterize MYBPC3 variants in a large, unrelated cohort of consecutive patients. Methods The MYBPC3 gene was screened by single-strand conformational polymorphism analysis and sequencing. The clinical phenotypes were analyzed using rest and 24-h electrocardiography, electrophysiology, two-dimensional and Doppler echocardiography and angiography. Results We identified 13 mutations in the: MYBPC3 gene: one nonsense, four missense and three splicing mutations and five small deletions and insertions. Of these, 11 were novel, and two were probably founder mutations. Patients with MYBPC3 mutations presented a broad range of phenotypes. In general the 16 carriers of protein truncations had a tendency toward earlier disease manifestations (33 +/- 13 vs. 48 +/-9 years; p = 0.06) and more frequently needed invasive procedures (septal ablation or cardioverter-defibrillator implantation) compared with the 9 carriers of missense mutations or in-frame deletions (12/16 vs. 1/9 patients; p < 0.01). Conclusions Multiple mutations, which include missense, nonsense and splicing mutations, as well as small deletions and insertions, occur in the MYBPC3 gene. Protein truncation mutations seem to cause a more severe disease phenotype than missense mutations or in-frame deletions. (J Am Coll Cardiol 2001;38:322-30) (C) 2001 by the American College of Cardiology.
引用
收藏
页码:322 / 330
页数:9
相关论文
共 31 条
[21]   The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: A unique profile of both independent and founder events [J].
Moolman-Smook, JC ;
De Lange, WJ ;
Bruwer, ECD ;
Brink, PA ;
Corfield, VA .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (05) :1308-1320
[22]   Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy [J].
Niimura, H ;
Bachinski, LL ;
Sangwatanaroj, S ;
Watkins, H ;
Chudley, AE ;
McKenma, W ;
Kristinsson, A ;
Roberts, R ;
Sole, M ;
Maron, BJ ;
Seidman, JG ;
Seidman, CE .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (18) :1248-1257
[23]   Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy - Characterization of cardiac transcript and protein [J].
Rottbauer, W ;
Gautel, M ;
Zehelein, J ;
Labeit, S ;
Franz, WM ;
Fischer, C ;
Vollrath, B ;
Mall, G ;
Dietz, R ;
Kubler, W ;
Katus, HA .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (02) :475-482
[24]   Structural analysis of the titin gene in hypertrophic cardiomyopathy: Identification of a novel disease gene [J].
Satoh, M ;
Takahashi, M ;
Sakamoto, T ;
Hiroe, M ;
Marumo, F ;
Kimura, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 262 (02) :411-417
[25]   ALPHA-TROPOMYOSIN AND CARDIAC TROPONIN-T MUTATIONS CAUSE FAMILIAL HYPERTROPHIC CARDIOMYOPATHY - A DISEASE OF THE SARCOMERE [J].
THIERFELDER, L ;
WATKINS, H ;
MACRAE, C ;
LAMAS, R ;
MCKENNA, W ;
VOSBERG, HP ;
SEIDMAN, JG ;
SEIDMAN, CE .
CELL, 1994, 77 (05) :701-712
[26]   HUMAN MYOSIN-BINDING PROTEIN-H (MYBP-H) - COMPLETE PRIMARY SEQUENCE, GENOMIC ORGANIZATION, AND CHROMOSOMAL LOCALIZATION [J].
VAUGHAN, KT ;
WEBER, FE ;
RIED, T ;
WARD, DC ;
REINACH, FC ;
FISCHMAN, DA .
GENOMICS, 1993, 16 (01) :34-40
[27]   Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy [J].
Vikstrom, KL ;
Factor, SM ;
Leinwand, LA .
MOLECULAR MEDICINE, 1996, 2 (05) :556-567
[28]   MUTATIONS IN THE GENES FOR CARDIAC TROPONIN-T AND ALPHA-TROPOMYOSIN IN HYPERTROPHIC CARDIOMYOPATHY [J].
WATKINS, H ;
MCKENNA, WJ ;
THIERFELDER, L ;
SUK, HJ ;
ANAN, R ;
ODONOGHUE, A ;
SPIRITO, P ;
MATSUMORI, A ;
MORAVEC, CS ;
SEIDMAN, JG ;
SEIDMAN, CE .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (16) :1058-1064
[29]   MUTATIONS IN THE CARDIAC MYOSIN BINDING PROTEIN-C GENE ON CHROMOSOME-11 CAUSE FAMILIAL HYPERTROPHIC CARDIOMYOPATHY [J].
WATKINS, H ;
CONNER, D ;
THIERFELDER, L ;
JARCHO, JA ;
MACRAE, C ;
MCKENNA, WJ ;
MARON, BJ ;
SEIDMAN, JG ;
SEIDMAN, CE .
NATURE GENETICS, 1995, 11 (04) :434-437
[30]   NOVEL INSIGHTS INTO THE CLINICAL MANIFESTATIONS AND TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY [J].
WIGLE, ED .
CURRENT OPINION IN CARDIOLOGY, 1995, 10 (03) :299-305